Renalytix Plc (LON:RENX – Get Free Report)’s stock price rose 6% during mid-day trading on Monday . The company traded as high as GBX 37 ($0.47) and last traded at GBX 34.55 ($0.44). Approximately 176,215 shares traded hands during trading, a decline of 75% from the average daily volume of 717,620 shares. The stock had previously closed at GBX 32.60 ($0.41).
Renalytix Price Performance
The company has a debt-to-equity ratio of 173.95, a current ratio of 0.59 and a quick ratio of 2.42. The company has a market capitalization of £41.20 million, a PE ratio of -98.16 and a beta of 1.92. The stock’s 50 day simple moving average is GBX 27.02 and its 200-day simple moving average is GBX 33.48.
Renalytix Company Profile
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from electronic health record systems to generate a unique patient risk score.
Further Reading
- Five stocks we like better than Renalytix
- What is a Secondary Public Offering? What Investors Need to Know
- Best Bear Market Funds: Top 3 Investment Options to Consider
- What is the Dogs of the Dow Strategy? Overview and Examples
- Is DraftKings A Good Bet Ahead of Q1 Earnings?
- How Can Investors Benefit From After-Hours Trading
- Mid-Cap Stocks to Outperform the Market This Cycle
Receive News & Ratings for Renalytix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Renalytix and related companies with MarketBeat.com's FREE daily email newsletter.
